T. Yamada

p28, A first in class peptide inhibitor of cop1 binding to p53

S. Cannistraro, C. Beattie, A. Bizzarri, 2013, British Journal of Cancer.

A first-in-class, first-in-human phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with metastatic refractory solid tumors.

C. Beattie, K. Christov, T. K. Das Gupta, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Crystal structure of NADH-dependent ferredoxin reductase component in biphenyl dioxygenase.

M. Fukuda, E. Masai, N. Sakurai, 2000, Journal of molecular biology.

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours

D. Majumdar, C. Beattie, K. Christov, 2013, British Journal of Cancer.

Monomeric structure of an active form of bovine cytochrome c oxidase

S. Yoshikawa, K. Shinzawa-Itoh, E. Yamashita, 2019, Proceedings of the National Academy of Sciences.